Acurx Pharmaceuticals, Inc. (ACXP) News
Track canonical SquawkNews coverage tagged to ACXP, Acurx Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ACXP Granted Patents in Japan and Mexico
Acurx Pharmaceuticals is granted new patents in Japan and Mexico for DNA Polymerase IIIC Inhibitor Antibiotics
EQUITY | Aug 12, 2026, 12:02 PM UTC
H
ACXP ACXP - FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including t
ACXP ACXP - FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single- Phase 3-Trial Registration Plan and a Trial Design to
EQUITY | Aug 03, 2026, 12:01 PM UTC